Literature DB >> 16518620

[Palliative bypass surgery].

A Wojtyczka1, T Moesta, C Kuntz, T Lehnert.   

Abstract

Impaired intestinal passage considerably reduces quality of life irrespective of the underlying condition. Limited life expectancy and increased operative risk of advanced malignant disease add particular weight to this issue. The indication for operative therapy results from carefully weighing individual incapacity and potential gain vs operative risk and life expectancy. Exactly because life expectancy is quite limited, selection of an effective, low-risk procedure is of utmost importance to benefit the patient.

Entities:  

Mesh：

Year:  2006        PMID： 16518620     DOI： 10.1007/s00104-006-1165-8

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


  39 in total

1.  A modification of segment III intrahepatic cholangiojejunostomy.

Authors:  Criostoir B O'Suilleabhain; Krishna K Madhavan
Journal:  Am J Surg       Date:  2004-01       Impact factor: 2.565

2.  Gastric bypass for malignant esophagotracheal fistula: a series of 21 cases.

Authors:  B Meunier; C Stasik; J L Raoul; Y Spiliopoulos; M Lakehal; J P Campion; B Launois
Journal:  Eur J Cardiothorac Surg       Date:  1998-02       Impact factor: 4.191

Review 3.  Palliative therapy for pancreatic/biliary cancer.

Authors:  Michael G House; Michael A Choti
Journal:  Surg Clin North Am       Date:  2005-04       Impact factor: 2.741

4.  Randomized trial of three types of gastrojejunostomy in unresectable periampullary cancer.

Authors:  Y M Shyr; C H Su; K L King; H C Wang; S S Lo; C W Wu; W Y Lui
Journal:  Surgery       Date:  1997-05       Impact factor: 3.982

5.  Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.

Authors:  K D Lillemoe; J L Cameron; J M Hardacre; T A Sohn; P K Sauter; J Coleman; H A Pitt; C J Yeo
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.

Authors:  J R Andersen; S M Sørensen; A Kruse; M Rokkjaer; P Matzen
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

7.  Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.

Authors:  S L Blair; D Z Chu; R E Schwarz
Journal:  Ann Surg Oncol       Date:  2001-09       Impact factor: 5.344

Review 8.  Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness.

Authors:  A Dormann; S Meisner; N Verin; A Wenk Lang
Journal:  Endoscopy       Date:  2004-06       Impact factor: 10.093

Review 9.  Systematic review of the efficacy and safety of colorectal stents.

Authors:  U P Khot; A Wenk Lang; K Murali; M C Parker
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

Review 10.  [Palliative surgical and endoscopic therapy of malignant bile duct occlusion].

Authors:  I Klempa; W Arnold
Journal:  Chirurg       Date:  1994-10       Impact factor: 0.955
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.